Cannabinoid substances – in the context of the current partial legalisation of cannabis, this somehow sounds like a narcotic. However, many of the 120 or so known cannabinoids are potent painkillers, including delta-9-THC (dronabinol), which doctors prescribe very specifically for certain chronic pains. Because the chemical synthesis used to date is not without its problems, researchers in the BigPharm project are looking for sustainable biotechnological alternatives.
Making greater use of the innovation potential of industrial biotechnology
Whether in food and agriculture, medicine, the chemical, cosmetics or pharmaceutical industry: biotechnology offers enormous innovation potential for many sectors. At the same time, industrial biotechnology in particular opens up ways for sustainable and resource-conserving economic activity and is therefore a key pillar of the bioeconomy. But what does it look like in practice? According to experts, Germany is lagging behind internationally in the industrial application of biotechnological processes.